Literature DB >> 28937851

HPV vaccine acceptability in high-risk Greek men.

Lea Hoefer1, Savas Tsikis1, George Bethimoutis2, Electra Nicolaidou2, Vassilios Paparizos2, Christina Antoniou2, Antonios Kanelleas2, Leonidas Chardalias3, Georgios-Emmanouil Stavropoulos3, John Schneider4,5, Angella Charnot-Katsikas6.   

Abstract

HPV is associated with malignancy in men, yet there is a lack of data on HPV knowledge, vaccine acceptability, and factors affecting vaccine acceptability in Greek men. This study aims to identify determinants of knowledge and willingness to vaccinate against HPV among high-risk Greek men. Men (n = 298) between the ages of 18 and 55 were enrolled from the STI and HIV clinics at "Andreas Syggros" Hospital in Athens, Greece from July-October 2015. Participants completed a survey on demographics, economic factors, sexual history, HPV knowledge, and vaccine acceptability. The majority of participants were younger than 40 (76.6%) and unmarried (84.6%). Our sample was 31.2% MSM (men who have sex with men), and 20.1% were HIV-positive. Most participants (>90%) were aware that HPV is highly prevalent in both men and women; however, fewer identified that HPV causes cancers in both sexes (68%) and that vaccination protects men and women (67%). Amongst participants, 76.7% were willing to vaccinate themselves against HPV, 71.4% an adolescent son, and 69.3% an adolescent daughter. HIV-positive men were more likely to be willing to vaccinate themselves (OR 2.83, p = .015), a son (OR 3.3, p = .015) or a daughter (3.01, p = .020). Higher income levels were associated with increased willingness to vaccinate oneself (OR 1.32, p = .027), a son (1.33, p = .032) or daughter (1.34, p = .027). Although there is a HPV knowledge gap, HPV vaccine acceptability is high despite lack of vaccine promotion to Greek men. Future studies should include lower-risk men to adequately inform public health efforts.

Entities:  

Keywords:  Attitudes; HPV; Men; Patients-views; Vaccination

Mesh:

Substances:

Year:  2017        PMID: 28937851      PMCID: PMC5791582          DOI: 10.1080/21645515.2017.1379640

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  28 in total

1.  Response to: Media effect-letter to the editor about the manuscript titled Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine.

Authors:  Alexandros Sotiriadis; Themistoklis Dagklis; Vaia Siamanta; Konstantinos Chatzigeorgiou; Theodoros Agorastos
Journal:  Arch Gynecol Obstet       Date:  2014-03       Impact factor: 2.344

Review 2.  Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.

Authors:  Dorothy A Machalek; Mary Poynten; Fengyi Jin; Christopher K Fairley; Annabelle Farnsworth; Suzanne M Garland; Richard J Hillman; Kathy Petoumenos; Jennifer Roberts; Sepehr N Tabrizi; David J Templeton; Andrew E Grulich
Journal:  Lancet Oncol       Date:  2012-03-23       Impact factor: 41.316

3.  Knowledge of human papillomavirus and anal cancer among men who have sex with men attending a New York City sexually transmitted diseases clinic.

Authors:  D M Sanchez; P Pathela; L M Niccolai; J A Schillinger
Journal:  Int J STD AIDS       Date:  2012-01       Impact factor: 1.359

4.  Knowledge of the HPV vaccine and its association with vaccine uptake among female higher-education students in Greece.

Authors:  Elisavet M Donadiki; Rodrigo Jiménez-García; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Ana López de Andrés; Isabel Jimenez-Trujillo; Emmanuel G Velonakis
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

5.  Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine.

Authors:  Alexandros Sotiriadis; Themistoklis Dagklis; Vaia Siamanta; Konstantinos Chatzigeorgiou; Theodoros Agorastos
Journal:  Arch Gynecol Obstet       Date:  2012-01-14       Impact factor: 2.344

6.  US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.

Authors:  Mona Saraiya; Elizabeth R Unger; Trevor D Thompson; Charles F Lynch; Brenda Y Hernandez; Christopher W Lyu; Martin Steinau; Meg Watson; Edward J Wilkinson; Claudia Hopenhayn; Glenn Copeland; Wendy Cozen; Edward S Peters; Youjie Huang; Maria Sibug Saber; Sean Altekruse; Marc T Goodman
Journal:  J Natl Cancer Inst       Date:  2015-04-29       Impact factor: 13.506

Review 7.  Prevalence of HPV infection among men: A systematic review of the literature.

Authors:  Eileen F Dunne; Carrie M Nielson; Katherine M Stone; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2006-09-12       Impact factor: 5.226

8.  Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.

Authors:  Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-27       Impact factor: 17.586

9.  Oral Human Papillomavirus (HPV) Infection among Unvaccinated High-Risk Young Adults.

Authors:  Gypsyamber D'Souza; Nicole Kluz; Alicia Wentz; Renee M Youngfellow; Anne Griffioen; Emily Stammer; Yingshi Guo; Weihong Xiao; Maura L Gillison
Journal:  Cancers (Basel)       Date:  2014-08-14       Impact factor: 6.639

10.  HPV and genital warts among Peruvian men who have sex with men and transgender people: knowledge, attitudes and treatment experiences.

Authors:  César R Nureña; Brandon Brown; Jerome T Galea; Hugo Sánchez; Magaly M Blas
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more
  3 in total

1.  Perceptions of nurses on human papillomavirus vaccinations in the Republic of Korea.

Authors:  Hae Won Kim; Hyang Yuol Lee; Seong Eun Kim; Hye Young Ahn; Yeon Hee Kim; Young Jin Lee
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

2.  Economic barriers, evidentiary gaps, and ethical conundrums: a qualitative study of physicians' challenges recommending HPV vaccination to older gay, bisexual, and other men who have sex with men.

Authors:  Daniel Grace; Mark Gaspar; Ron Rosenes; Ramandip Grewal; Ann N Burchell; Troy Grennan; Irving E Salit
Journal:  Int J Equity Health       Date:  2019-10-17

3.  Knowledge, Attitudes and Perceptions about Cervical Cancer Risk, Prevention and Human Papilloma Virus (HPV) in Vulnerable Women in Greece.

Authors:  Elena Riza; Argiro Karakosta; Thomas Tsiampalis; Despoina Lazarou; Angeliki Karachaliou; Spyridon Ntelis; Vasilios Karageorgiou; Theodora Psaltopoulou
Journal:  Int J Environ Res Public Health       Date:  2020-09-21       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.